OSCR

Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression.

Code ↔ Paper

2 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

2 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.

The 2 matches
  1. [1] § Results › Integrative multi-omics validation pinpoints key proteins ↔ run_scRNA_DEA.R, lines 1 to 43 · score 0.77 · oligodendrocyte precursor cell, endothelial cells, single cell, RNA, astrocyte, neuron · block oscr:b:M65WM8AGWSM2E-P · Report a mismatch
  2. [2] § Methods › Statistical analysis › Validating proteins using causal evidence from MR ↔ run_MR.R, lines 54 to 119 · score 0.57 · Wald ratio, error, IVW, MR, exposure, R2 · block oscr:b:SV8C70Z6P71NA-I · Report a mismatch

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 112 lines · 2.8 KB · no license · 1 match

  1. #!/usr/bin/env Rscript
  2. suppressPackageStartupMessages({
  3. library(Seurat)
  4. library(data.table)
  5. })
  6. # =========================
  7. # Inputs (edit here)
  8. # =========================
  9. seurat_rds <- "data/scRNA/ms_single_cell.rds"
  10. outdir <- "results/scRNA_DE"
  11. # cell types to keep (edit to your study)
  12. cell_types_to_keep <- c(
  13. "microglial cell",
  14. "oligodendrocyte",
  15. "oligodendrocyte precursor cell",
  16. "astrocyte",
  17. "endothelial cell",
  18. "neuron",
  19. "pericyte",
  20. "progenitor cell"
  21. )
  22. # target genes (Ensembl IDs in your example)
  23. target_genes <- c(
  24. "ENSG00000197959", # DNM3 (example)
  25. "ENSG00000075292", # ZNF638
  26. "ENSG00000174227", # PIGG
  27. "ENSG00000135636" # DYSF
  28. )
  29. # disease labels in metadata
  30. group_var <- "disease"
  31. case_level <- "multiple sclerosis"
  32. ctrl_level <- "normal"
  33. # FindMarkers settings (minimal & robust)
  34. min_pct <- 0.1
  35. test_use <- "wilcox"
  36. dir.create(outdir, recursive = TRUE, showWarnings = FALSE)
  37. # =========================
  38. # Load Seurat object
  39. # =========================
  40. obj <- readRDS(seurat_rds)
  41. # Required metadata checks
  42. meta_cols <- colnames([email hidden])
  43. stopifnot("cell_type" %in% meta_cols)
  44. stopifnot(group_var %in% meta_cols)
  45. # Subset cell types of interest
  46. obj <- subset(obj, subset = cell_type %in% cell_types_to_keep)
  47. # Keep only target genes present in object
  48. target_present <- intersect(target_genes, rownames(obj))
  49. if (length(target_present) == 0) {
  50. stop("None of target_genes found in Seurat object rownames().")
  51. }
  52. # =========================
  53. # Differential expression per cell type
  54. # =========================
  55. res_list <- list()
  56. for (ct in cell_types_to_keep) {
  57. sub <- subset(obj, subset = cell_type == ct)
  58. # check both groups exist
  59. groups <- unique(as.character([email hidden][[group_var]]))
  60. if (!(case_level %in% groups && ctrl_level %in% groups)) {
  61. message("[SKIP] ", ct, ": missing one of groups (", ctrl_level, ", ", case_level, ")")
  62. next
  63. }
  64. # run DE only on target genes (fast + focused)
  65. mk <- FindMarkers(
  66. object = sub,
  67. group.by = group_var,
  68. ident.1 = case_level,
  69. ident.2 = ctrl_level,
  70. features = target_present,
  71. logfc.threshold = 0,
  72. min.pct = min_pct,
  73. test.use = test_use
  74. )
  75. if (nrow(mk) == 0) next
  76. mk$gene <- rownames(mk)
  77. mk$cell_type <- ct
  78. # FDR
  79. mk$p_val_adj_fdr <- p.adjust(mk$p_val, method = "fdr")
  80. res_list[[ct]] <- mk
  81. }
  82. res <- data.table::rbindlist(res_list, fill = TRUE)
  83. # Save
  84. data.table::fwrite(res, file.path(outdir, "MS_vs_normal_DE_target_genes.tsv"), sep = "\t")
  85. # Also save significant results only
  86. res_sig <- res[p_val_adj_fdr < 0.05]
  87. data.table::fwrite(res_sig, file.path(outdir, "MS_vs_normal_DE_target_genes_sig.tsv"), sep = "\t")
  88. message("[DONE] Wrote results to: ", outdir)

run_scRNA_DEA.R at commit d2cb5ff, no license · at the source

Overview

Authors: Yuan Jiang1, Jinyu Xiao2,1, Ingrid Kockum1, Pernilla Stridh1, Qianwen Liu1, Tomas Olsson1, Lars Alfredsson3,1, Xia Jiang1,2
  1. Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77 Sweden
  2. Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 610041 Chengdu, China
  3. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177 Sweden
Journal: Journal of neuroinflammation, volume 23, issue 1, article 198
Dates: received 5 November 2025; accepted 27 May 2026; published online 2 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s12974-026-03895-z · PMID 42231304 · PMCID PMC13261964 · OpenAlex W7163237096
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), multiple sclerosis (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Preprocessing
Keywords: Progressive multiple sclerosis, Protein, Drug targets, Omics
MeSH: Disease Progression*, Multiple Sclerosis*, Genome-Wide Association Study, Humans, Multiomics, Proteomics (* major topic)
Topic: Multiple Sclerosis Research Studies (Clinical Neurology, Medicine), according to OpenAlex
Funding: Karolinska Institute
Citations: not cited yet (Europe PMC); 51 references in the paper

Abstract

Introduction: Current therapies for multiple sclerosis (MS) primarily reduce relapse rates and delay disability by targeting inflammation, while have limited efficacy against disease progression driven by neurodegenerative processes. We sought to identify and validate proteins for MS progression by integrating a large genome-wide association study (GWAS) of MS progression with large-scale protein quantitative trait loci data from blood and brain.

Methods: We conducted proteome-wide association studies (PWAS) to nominate proteins; applied summary-data Mendelian randomization and colocalization to evaluate association; and performed functional annotation (pathway enrichment, drug-target mapping, and protein-protein interaction networks) to prioritize therapeutic potential. Additionally, we performed external validation through bulk and cell-type-specific expression analyses and prioritized protein evaluation. The final key proteins were determined by triangulating evidence across all these streams.

Results: We identified 48 genetically prioritized proteins. Functional annotation prioritized 14 with therapeutic potential and highlighted 13 non-MS drugs for repurposing. Triangulation of evidence with multi-omics external validation highlighted six key proteins: RRM2B (a Cladribine target), CBR1, and ETFA, which are linked to existing drugs; DNM3 (a GWAS-implicated locus), CAB39L, and NMRAL1, which emerged as validated novel proteins providing biological insight into MS progression.

Conclusion: Our multi-omics integration prioritizes proteins implicated in MS progression, providing mechanistic insights into neurodegeneration and a foundation for future therapeutic exploration in progressive MS.

Supplementary Information: The online version contains supplementary material available at 10.1186/s12974-026-03895-z.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above, with 2 matches between paragraphs and lines of code.

Yuanjiang1110/MS-progression-drug-targets

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Commit: d2cb5ff554886c9155b88c851c89cc742426c410, 4 March 2026
Languages: R (3), Shell (3)
Size: 7 files, 6 scripts
Software Heritage: not archived
Found in: “Code availability”
Holds: README
Not found: license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: data.table (3 files), Seurat (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers
  • 27 September 2026: the link answers
7 files

Code availability

The R scripts and analytical pipelines used to generate the results of this study are available on GitHub at: [https://github.com/Yuanjiang1110/MS-progression-drug-targets].

Reproduced under the paper's license (CC BY), from the paper cited above.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 6 scripts, each with its path and the digest of its content;
  • 2 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Data availability

All the genetic and QTL data used in this study were from the publicly accessible summary statistics and can be accessed through the corresponding references presented in the main text.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 4 keywords, 6 MeSH terms, 1 funder, 51 references.

Cite

This paper

Jiang, Y., Xiao, J., Kockum, I., Stridh, P., Liu, Q., Olsson, T., Alfredsson, L., & Jiang, X. (2026). Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. Journal of neuroinflammation, 23(1), 198. https://doi.org/10.1186/s12974-026-03895-z

BibTeX

@article{jiang2026multi,
author = {Jiang, Yuan and Xiao, Jinyu and Kockum, Ingrid and Stridh, Pernilla and Liu, Qianwen and Olsson, Tomas and Alfredsson, Lars and Jiang, Xia},
title = {{Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression}},
journal = {Journal of neuroinflammation},
year = {2026},
month = jun,
volume = {23},
number = {1},
pages = {198},
publisher = {BMC},
issn = {1742-2094},
doi = {10.1186/s12974-026-03895-z},
url = {https://doi.org/10.1186/s12974-026-03895-z},
pmid = {42231304},
pmcid = {PMC13261964}
}

RIS

TY - JOUR
AU - Jiang, Yuan
AU - Xiao, Jinyu
AU - Kockum, Ingrid
AU - Stridh, Pernilla
AU - Liu, Qianwen
AU - Olsson, Tomas
AU - Alfredsson, Lars
AU - Jiang, Xia
TI - Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression
T2 - Journal of neuroinflammation
J2 - J Neuroinflammation
PY - 2026
DA - 2026/06/02
VL - 23
IS - 1
SP - 198
SN - 1742-2094
PB - BMC
DO - 10.1186/s12974-026-03895-z
UR - https://doi.org/10.1186/s12974-026-03895-z
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s12974-026-03895-z",
"type": "article-journal",
"title": "Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression",
"container-title": "Journal of neuroinflammation",
"author": [
{
"family": "Jiang",
"given": "Yuan"
},
{
"family": "Xiao",
"given": "Jinyu"
},
{
"family": "Kockum",
"given": "Ingrid"
},
{
"family": "Stridh",
"given": "Pernilla"
},
{
"family": "Liu",
"given": "Qianwen"
},
{
"family": "Olsson",
"given": "Tomas"
},
{
"family": "Alfredsson",
"given": "Lars"
},
{
"family": "Jiang",
"given": "Xia"
}
],
"container-title-short": "J Neuroinflammation",
"volume": "23",
"issue": "1",
"page": "198",
"DOI": "10.1186/s12974-026-03895-z",
"PMID": "42231304",
"PMCID": "PMC13261964",
"ISSN": "1742-2094",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s12974-026-03895-z",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
2
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/ijms27167275 [code]
Integrative Multi-Omics Analysis of Multiple Sclerosis Reveals Cell-Type-Specific Regulatory Landscapes and Discordant Methylation-Expression Coupling.
Journal: International journal of molecular sciences
In common: data.table, multiple sclerosis, genetics / omics, cellular / molecular, 5 references
[2] doi:10.1038/s41467-024-50794-z [code]
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis.
Journal: Nature communications
In common: multiple sclerosis, genetics / omics, cellular / molecular, 1 reference, author Ingrid Kockum
[3] doi:10.1371/journal.pcbi.1014422 [code]
Deciphering cell type-specific causal genetic effects on brain imaging-derived phenotypes and disorders with single-cell Mendelian randomization.
Journal: PLoS computational biology
In common: data.table, genetics / omics, cellular / molecular, 4 references
[4] doi:10.1038/s41467-025-63371-9 [code]
Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids.
Journal: Nature communications
In common: Seurat, data.table, multiple sclerosis, genetics / omics, cellular / molecular, 2 references
[5] doi:10.1212/nxi.0000000000200213 [code]
Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
Journal: Neurology(R) neuroimmunology & neuroinflammation
In common: Seurat, data.table, multiple sclerosis, genetics / omics, cellular / molecular, 2 references
[6] doi:10.3389/fbinf.2026.1832826 [code]
Spatial transcriptomics reveal heterogeneous cell‒cell interactions among brain regions in cuprizone model consistent with multiple sclerosis lesions.
Journal: Frontiers in bioinformatics
In common: Seurat, multiple sclerosis, genetics / omics, cellular / molecular, 3 references
[7] doi:10.1016/j.ebiom.2023.104631 [code]
Dilated Virchow-Robin spaces are a marker for arterial disease in multiple sclerosis.
Journal: EBioMedicine
In common: multiple sclerosis, author Ingrid Kockum
[8] doi:10.1093/braincomms/fcaf152 [code]
Brain age in multiple sclerosis: a study with deep learning and traditional machine learning.
Journal: Brain communications
In common: multiple sclerosis, author Ingrid Kockum
[9] doi:10.1038/s41588-024-02050-9 [code]
Cell state-dependent allelic effects and contextual Mendelian randomization analysis for human brain phenotypes.
Journal: Nature genetics
In common: Seurat, data.table, genetics / omics, cellular / molecular, 2 references
[10] doi:10.1038/s41588-025-02291-2 [code]
Multiancestry brain pQTL fine-mapping and integration with genome-wide association studies of 21 neurologic and psychiatric conditions.
Journal: Nature genetics
In common: genetics / omics, cellular / molecular, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z.svg)](https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z.svg
   :target: https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z"><img src="https://openscicode.org/badge/doi/10.1186/s12974-026-03895-z.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.